Cepheid (NASDAQ:CPHD)
CAPS Rating:
A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.
RSS Headlines
Fool UK
Recs
a solid company with products coming to market that have little to no competition, but pressing demand and need((rapid HPV staph infection testing . a must buy